Wockhardt surges after breakthrough US cancer treatment with Zaynich
Wockhardt surged 2.03% to Rs 1452.60 after the company announced that its novel antibiotic Zaynich (Zidebactam/Cefepime, WCK 5222) successfully treated a US pediatric cancer patient suffering from a ...